Dow Down 0.84% Nasdaq Down 0.45%
Streaming
Ticker Tape: On

Actavis, Inc. (ACT)

-NYSE

144.93 Down 0.17(0.12%) 10:47AM EDT - Nasdaq Real Time Price

Add to Portfolio
Prev Close:145.10
Open:145.00
Bid:145.24 x 600
Ask:145.31 x 200
1y Target Est:152.73
Beta:N/A
Next Earnings Date:29-Oct-13ACT Earnings announcement
Day's Range:144.55 - 147.48
52wk Range:81.73 - 147.48
Volume:485,979
Avg Vol (3m):1,311,090
Market Cap:19.30B
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACTDown 0.12%19.30B
DRREDDY.BOUp 1.00%409.46B
DRREDDY.NSUp 1.11%409.46B
HIK.LUp 0.10%2.08B
DIVISLAB.NSUp 2.32%131.78B

Key Statistics

Forward P/E (1 yr):11.71
P/S (ttm):2.79
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :8.34
Quarterly EPS Est (Sep-13) :2.08
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):0.91

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Actavis, Inc., an integrated specialty pharmaceutical company, engages in developing, manufacturing, marketing, selling, and distributing generic, branded generic, brand, biosimilar, and over-the-counter pharmaceutical products worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback